Bupropion in Reducing Cancer Related Fatigue in Stage I-III Breast Cancer Survivors
Study Number: URCC 18007
This phase III trial studies how well bupropion works in reducing cancer related fatigue in stage I-III breast cancer survivors. Bupropion is a drug that is used to treat depression, as well as to help people quit smoking. Cancer and its treatment can cause fatigue. Giving bupropion may improve cancer related fatigue in breast cancer survivors.
- Courtney, 309-243-3660 firstname.lastname@example.org
- Hannah S, 309-243-3603, email@example.com
- Kelsey, 309-243-3618 firstname.lastname@example.org